Annotated Medicine and Device Lists

Hydroxycarbamide

Solid oral dosage form 200 mg Solid oral dosage form 250 mg Solid oral dosage form 300 mg Solid oral dosage form 400 mg Solid oral dosage form 500 mg Solid oral dosage form 1 g

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	10.3. Other medicines for haemoglobinopathies	No observations
WHO Model List of Essential Medicines (2021)	8.2.1 Cytotoxic medicines	Others observations: − Chronic myeloid leukaemia

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	8.2.1 Cytotoxic medicines	Others observations: − Chronic myeloid leukaemia

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	8.2.1 Cytotoxic medicines	Others observations: − Chronic myeloid leukaemia

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	8.2.1 Cytotoxic medicines	Others observations: − Chronic myeloid leukaemia

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	10.3. Other medicines for haemoglobinopathies	No observations
Peru	8.2 Cytotoxics	No observations
WHO Model List of Essential Medicines (2021)	8.2.1 Cytotoxic medicines	Others observations: − Chronic myeloid leukaemia

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	10.3. Other medicines for haemoglobinopathies	No observations
WHO Model List of Essential Medicines (2021)	8.2.1 Cytotoxic medicines	Others observations: − Chronic myeloid leukaemia

Information Resources: Hydroxycarbamide

No information available